Giuditta Rurale
Research Subjects
Giuditta Rurale has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Federica Marelli
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
2 shared publications - Luca Persani
Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
2 shared publications - Silvia Carra
Laboratory of Endocrine and Metabolic Research, IRCCS, Istituto Auxologico Italiano, Cusano Milanino, 20095 Milan, Italy
2 shared publications - Franco Cotelli
Department of Biology, University of Milan, Milan, Italy
1 shared publication
Latest Publications
- 3 May 2017
- Published by Bioscientifica in Endocrine Abstracts
The human TR[alpha] variants affect the specification of haematopoietic stem cells during zebrafish haematopoiesis
Anaemia in RTHα patients correlates with documented abnormal erythropoiesis and reduced haematocrit in TRα-null or mutant mice, but the underlying mechanisms and characterization of the defect remain elusive. In a previous work, we described that the injection of several hTRα variants in zebrafish eggs caused a marked reduction of circulating erythrocytes at later stages of the erythropoiesis. To characterise the involvement of TRα during erythrocyte development, we analysed by qRT-PCR and in situ hybridization (ISH) the expression of different haematopoietic markers. We microinjected the zebrafish eggs at 1–2 cells stage with 80pg/embryos of the purified mRNAs of several hTRα variants, and from the 6-hpf, the injected embryos were treated with the control vehicle, or with 20 μM-T3, added in the harvested water. By qRT-PCR, the expression of genes involved in the specification of lateral mesoderm (cdx4, bmp2b, smad5, chd), induction and proliferation of haematopoietic stem cells (HSC) (tal1, lmo2, gata1, gata2) and proliferation of erythrocytes (zin, grx5, cia, cha) appeared significantly reduced in all hTRα-injected embryos. Consistent with previous results, the treatment with high T3 doses can rescue the DN-activity of the missense variants D211G and A263V, whereas the truncated receptors A382PfsX7, E403X and F397fs406X are unaffected by TH treatment. Furthermore, we analysed the specification of HSC in embryos at 8-somite stage, by ISH. The vast majority of the hTRα-injected embryos showed a reduced or undetectable expression of early erythropoiesis markers, such as c-myb, pu.1, tal1 and gata1 in anterior or posterior lateral mesoderm. At 36-hpf, we also observed a dramatic reduction of gata1 in the intermediated cell mass of hTRα-injected embryos. Therefore, our results highlight a relevant role for TRα during the early phases of the primitive haematopoiesis, when the HSC start to proliferate and differentiate. Research founding: IAI-Ricerca Corrente RF-2011 05C102.
- 3 May 2017
- Published by Bioscientifica in Endocrine Abstracts
The human TR[alpha] variants affect the specification of haematopoietic stem cells during zebrafish haematopoiesis
Anaemia in RTHα patients correlates with documented abnormal erythropoiesis and reduced haematocrit in TRα-null or mutant mice, but the underlying mechanisms and characterization of the defect remain elusive. In a previous work, we described that the injection of several hTRα variants in zebrafish eggs caused a marked reduction of circulating erythrocytes at later stages of the erythropoiesis. To characterise the involvement of TRα during erythrocyte development, we analysed by qRT-PCR and in situ hybridization (ISH) the expression of different haematopoietic markers. We microinjected the zebrafish eggs at 1–2 cells stage with 80pg/embryos of the purified mRNAs of several hTRα variants, and from the 6-hpf, the injected embryos were treated with the control vehicle, or with 20 μM-T3, added in the harvested water. By qRT-PCR, the expression of genes involved in the specification of lateral mesoderm (cdx4, bmp2b, smad5, chd), induction and proliferation of haematopoietic stem cells (HSC) (tal1, lmo2, gata1, gata2) and proliferation of erythrocytes (zin, grx5, cia, cha) appeared significantly reduced in all hTRα-injected embryos. Consistent with previous results, the treatment with high T3 doses can rescue the DN-activity of the missense variants D211G and A263V, whereas the truncated receptors A382PfsX7, E403X and F397fs406X are unaffected by TH treatment. Furthermore, we analysed the specification of HSC in embryos at 8-somite stage, by ISH. The vast majority of the hTRα-injected embryos showed a reduced or undetectable expression of early erythropoiesis markers, such as c-myb, pu.1, tal1 and gata1 in anterior or posterior lateral mesoderm. At 36-hpf, we also observed a dramatic reduction of gata1 in the intermediated cell mass of hTRα-injected embryos. Therefore, our results highlight a relevant role for TRα during the early phases of the primitive haematopoiesis, when the HSC start to proliferate and differentiate. Research founding: IAI-Ricerca Corrente RF-2011 05C102.
- 13 May 2016
- Published by Bioscientifica in Endocrine Abstracts
Zebrafish as a new model to studyin vivothe functional consequences of human THRA variants
Introduction: Since 2012, different heterozygous mutations in the THRA gene have been described in patients with resistance to thyroid hormone alpha (RTHα). The associating symptoms are reminiscent of untreated congenital hypothyroidism (growth retardation, psycho-neuromotor disorders, delayed bone development and bradycardia) but with raised T3/T4 ratio and normal TSH levels. All genetic abnormalities act in a dominant negative (DN) manner against functional receptors due to reduced T3-binding or defective interaction with corepressors or coactivators of the ligand-binding domain. Therefore, RTHα patients present variable sensitivity to TH treatment. We previously described that zebrafish embryos expressing a DN form of thraa recapitulate the key features of RTHα, and that zebrafish and human receptors are functionally interchangeable. Methods: In this work, we present a simplified model obtained by direct mRNA microinjection into zebrafish eggs of several human THRA variants (D211G, A263V, A382PfsX7, E403X and F397fs406X). Using a series of molecular and analytical approaches (WISH, IHC, ELISA) we studied the embryonic development of cardiovascular, skeletal and nervous systems, which are directly involved in the T3-dependent TRα action. Additionally, thyroid and pituitary function, as well as the T3 and T4 contents were analysed. Results: All THRA-injected embryos show defects in several tissues of variable entity: altered cardiovascular development, incomplete formation of cartilages and bones, reduced number motorneurons that is reflected by defective zebrafish locomotion. Furthermore, changes in deiodinases expression (high dio2, low dio3a and dio3b levels) in presence of normal thyroid and pituitary markers, could explain the high T3/T4 ratio observed in THRA-injecting embryos, as in RTHα cases. Interestingly, the treatment with high T3 dose efficiently rescue most of these defects only in D211G- and A263V-injected embryos, conserving part of the T3-binding activity and transactivation properties. Conclusion: Zebrafish represent a new ‘biotool’ to delineate the functional impact of new THRA variants in vivo.
- 13 May 2016
- Published by Bioscientifica in Endocrine Abstracts
Zebrafish as a new model to studyin vivothe functional consequences of human THRA variants
Introduction: Since 2012, different heterozygous mutations in the THRA gene have been described in patients with resistance to thyroid hormone alpha (RTHα). The associating symptoms are reminiscent of untreated congenital hypothyroidism (growth retardation, psycho-neuromotor disorders, delayed bone development and bradycardia) but with raised T3/T4 ratio and normal TSH levels. All genetic abnormalities act in a dominant negative (DN) manner against functional receptors due to reduced T3-binding or defective interaction with corepressors or coactivators of the ligand-binding domain. Therefore, RTHα patients present variable sensitivity to TH treatment. We previously described that zebrafish embryos expressing a DN form of thraa recapitulate the key features of RTHα, and that zebrafish and human receptors are functionally interchangeable. Methods: In this work, we present a simplified model obtained by direct mRNA microinjection into zebrafish eggs of several human THRA variants (D211G, A263V, A382PfsX7, E403X and F397fs406X). Using a series of molecular and analytical approaches (WISH, IHC, ELISA) we studied the embryonic development of cardiovascular, skeletal and nervous systems, which are directly involved in the T3-dependent TRα action. Additionally, thyroid and pituitary function, as well as the T3 and T4 contents were analysed. Results: All THRA-injected embryos show defects in several tissues of variable entity: altered cardiovascular development, incomplete formation of cartilages and bones, reduced number motorneurons that is reflected by defective zebrafish locomotion. Furthermore, changes in deiodinases expression (high dio2, low dio3a and dio3b levels) in presence of normal thyroid and pituitary markers, could explain the high T3/T4 ratio observed in THRA-injecting embryos, as in RTHα cases. Interestingly, the treatment with high T3 dose efficiently rescue most of these defects only in D211G- and A263V-injected embryos, conserving part of the T3-binding activity and transactivation properties. Conclusion: Zebrafish represent a new ‘biotool’ to delineate the functional impact of new THRA variants in vivo.